Search clinical trials for: Xaliproden

Total 6 results

Sanofi

Completed

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Alzheimer Disease

United States, France, Netherlands, Spain, Singapore, Taiwan, Hong Kong, South Africa, Australia, Italy
Sanofi

Completed

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Alzheimer Disease

United States, Canada
Nantes University Hospital

Recruiting

Dynamic 99mTc-Tetrofosmin CZT-SPECT Myocardial Perfusion Imaging in Comparison With Fractional Flow Reserve in Patients After ST-elevation Myocardial Infarction (Dyna-MI)

Myocardial Infarction

France
Sanofi

Completed

Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.

Colorectal Neoplasms | Colorectal Carcinoma | Metastases

United States, Canada, Brazil, Poland, Australia, Germany, Italy, Portugal, Spain, Argentina, Hungary, United Kingdom, Chile
Sanofi

Completed

XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy

Colorectal Neoplasms | Colorectal Carcinoma | Metastases
Sanofi

Terminated

Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens (XENON)

Colorectal Neoplasms

France, Spain, United States, Greece, Italy, United Kingdom, Germany, Canada

3

Subscribe